Peter Jüni

RoB 2: a revised tool for assessing risk of bias in randomised trials

2019 · BMJ

Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We …

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

2019 · European Heart Journal

The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC …

2017 ESC/EACTS Guidelines for the management of valvular heart disease

2017 · European Heart Journal

The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) The disclosure forms of all experts involved in the development …

2021 ESC/EACTS Guidelines for the management of valvular heart disease

2021 · European Heart Journal

International audience